Detalhe da pesquisa
1.
Dramatic secukinumab-mediated improvements in refractory leprosy-related neuritis via the modulation of T helper 1 (Th1) and T helper 17 (Th17) immune pathways.
Rev Soc Bras Med Trop
; 54: e03362021, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34932761